Abstract:Backgroud: The co-administration of Chinese patent medicine with calcium channel blockers (CCBs) is a prevalent practice in China for treating essential hypertension (EH). However, robust evidence supporting the efficacy and safety of tailored combinations of different Chinese patent medicines with CCBs, according to individual patient conditions, is still limited. This study sought to elucidate the efficacy and safety of these combinations using a systematic review and network meta-analysis. Materials and methods: Relevant studies were sourced from established databases, incorporating randomized controlled trials published up to 1 February 2023. The ROB2 tool from the Cochrane Collaborative Network was employed to independently assess and cross-verify the quality of the included literature. A network meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) 2020 and PRISMA-Network Meta-Analyses (PRISMA-NMA) guidelines. A Bayesian network meta-analysis was utilized to gauge the efficacy and safety of distinct integrations of Chinese patent medicine and CCBs. Primary outcomes were interpreted using a paired fixed-effect meta-analysis. Publication bias was appraised through Egger's test and represented with funnel plots. All statistical analyses were executed within the R statistical framework. Results: Following rigorous selection, data extraction, and bias evaluation, 36 articles were incorporated. Tianma Gouteng Granule, when combined with CCBs, displayed superior efficacy in reducing systolic blood pressure (SBP). In terms of diastolic blood pressure (DBP) reduction, Songling Xuemaikang Capsule combined with CCBs emerged as the most effective. Regarding enhancement of antihypertensive effective rates, Qinggan Jiangya Capsule paired with CCBs demonstrated optimal results. For diminishing Traditional Chinese Medicine syndrome scores, the Qiangli Dingxuan Tablet and CCBs combination proved most beneficial. When aiming to reduce total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C) levels, Tianma Gouteng Granule and CCBs showcased superior results. In contrast, the combination of Songling Xuemaikang Capsule and CCBs was more effective in reducing LDL-C, tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6). Conclusion: This study underscores variability in outcomes from combining Chinese patent medicine and CCBs for hypertension, emphasizing the importance of personalized medicinal combinations, especially Tianma Gouteng Granule and Songling Xuemaikang Capsule. The results offer robust evidence to inform clinical guidelines for essential hypertention and significantly aid clinician in seleting appropriate Chinese patent medicines for treatment.

Adverse Reaction of Commonly Used Anti-Hypertensives and Safety Countermeasure on Clinic

Drug Utilization of Antihypertensives for Outpatients in a General Hospital

Analysis of Outpatient Prescriptions of Antihypertensive Drugs

A profile of adverse effects of antihypertensive medicines in a tertiary care clinic in Nigeria

Adverse Reaction of Acupuncture and Antihypertensive Drugs for Treatment of Essential hypertension: A Protocol for Bayesian Network Meta-Analysis

Analysis of Top 5 Drugs in the Adverse Drug Reaction Report Database of Zhenjiang City in Recent 10 Years

Considering Adverse Effects of Common Antihypertensive Medications in the ED

Overview of Clinical Use and Side Effect Profile of Valsartan in Chinese Hypertensive Patients

Chinese herbal medicine formula combined with calcium antagonist in the treatment of hypertension: a systematic review and meta-analysis

Analysis of Adverse Drug Reactions in 468 Cases

Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science

Efficacy,safety Analysis and Pharmacoeconomics Research on 26 Kinds of Routine Antihypertens-Ives

Systematic Review of Therapeutic Efficacy and Safety of Enalapril in the Treatment of Essential Hypertension

ADRs monitoring and analysis of cardiovascular drugs

Herbal medicine (Zhengan Xifeng Decoction) for essential hypertension protocol for a systematic review and meta-analysis

Chinese patent medicine combined with calcium channel blockers in the treatment of essential hypertension:a Bayes network meta-analysis and systematic review

Characteristics of Hypertension in Chinese and Their Relevance for the Choice of Antihypertensive Drugs

Analysis on Adverse Drug Reactions in Our Hospital from 2008 to 2010

Characteristics of hypertension in Chinese and their relevance for the choice of antihypertensive drugs.

Effects of Comprehensive Healthy Educational Mode on Safety Using Thiazide Diuretics among Hypertensive Patients

The Antihypertensive Efficacy and Safety of Benazepril in Chinese Population: a Meta-Analysis of Randomized Controlled Trials